PIPAMAZINE


SMILES NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
InChIKey OSJJYEUEJRVVOD-UHFFFAOYSA-N

Chemical properties

Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 5
Molecular weight (Da) 401.1

Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug No

Database connections


Bioactivities

Receptor Activity Source
GTP Uniprot Species Family Class Type Min Avg Max Database
5-HT1B 5HT1B Rat 5-Hydroxytryptamine A pKi 5.86 5.86 5.86 ChEMBL
α1B ADA1B Rat Adrenoceptors A pKi 8.85 8.85 8.85 ChEMBL
α1A ADA1A Rat Adrenoceptors A pKi 8.68 8.68 8.68 ChEMBL
α1D ADA1D Human Adrenoceptors A pKi 9.02 9.02 9.02 ChEMBL
α2B ADA2B Human Adrenoceptors A pKi 9.11 9.11 9.11 ChEMBL
M5 ACM5 Human Acetylcholine (muscarinic) A pKi 5.65 5.65 5.65 ChEMBL
α2C ADA2C Human Adrenoceptors A pKi 8.19 8.19 8.19 ChEMBL
H1 HRH1 Human Histamine A pKi 8.94 8.94 8.94 ChEMBL
5-HT1A 5HT1A Rat 5-Hydroxytryptamine A pKi 5.99 5.99 5.99 ChEMBL
α2A ADA2A Human Adrenoceptors A pKi 7.6 7.6 7.6 ChEMBL
D1 DRD1 Human Dopamine A pKi 7.8 7.8 7.8 ChEMBL
5-HT6 5HT6R Human 5-Hydroxytryptamine A pKi 7.28 7.28 7.28 ChEMBL
5-HT2B 5HT2B Human 5-Hydroxytryptamine A pKi 7.51 7.51 7.51 ChEMBL
5-HT2C 5HT2C Human 5-Hydroxytryptamine A pKi 7.96 7.96 7.96 ChEMBL
D3 DRD3 Human Dopamine A pKi 8.8 8.8 8.8 ChEMBL
5-HT2A 5HT2A Human 5-Hydroxytryptamine A pKi 9.26 9.26 9.26 ChEMBL
D2 DRD2 Human Dopamine A pKi 8.87 8.87 8.87 ChEMBL
5-HT1A 5HT1A Human 5-Hydroxytryptamine A pKi 8.22 8.22 8.22 Drug Central
5-HT2A 5HT2A Human 5-Hydroxytryptamine A pKi 8.03 8.03 8.03 Drug Central
5-HT2B 5HT2B Human 5-Hydroxytryptamine A pKi 8.12 8.12 8.12 Drug Central
5-HT2C 5HT2C Human 5-Hydroxytryptamine A pKi 8.1 8.1 8.1 Drug Central
M5 ACM5 Human Acetylcholine (muscarinic) A pKi 8.25 8.25 8.25 Drug Central
α1D ADA1D Human Adrenoceptors A pKi 8.04 8.04 8.04 Drug Central
α2A ADA2A Human Adrenoceptors A pKi 8.12 8.12 8.12 Drug Central
α2B ADA2B Human Adrenoceptors A pKi 8.04 8.04 8.04 Drug Central
α2C ADA2C Human Adrenoceptors A pKi 8.09 8.09 8.09 Drug Central
D1 DRD1 Human Dopamine A pKi 8.11 8.11 8.11 Drug Central
D2 DRD2 Human Dopamine A pKi 8.05 8.05 8.05 Drug Central
D3 DRD3 Human Dopamine A pKi 8.06 8.06 8.06 Drug Central
H1 HRH1 Human Histamine A pKi 8.05 8.05 8.05 Drug Central
α1B ADA1B Rat Adrenoceptors A pKi 8.05 8.05 8.05 Drug Central
5-HT6 5HT6R Human 5-Hydroxytryptamine A pKi 8.14 8.14 8.14 Drug Central
5-HT1B 5HT1B Rat 5-Hydroxytryptamine A pKi 8.23 8.23 8.23 Drug Central
Receptor Activity Source
GTP Uniprot Species Family Class Type Min Avg Max Database
5-HT1B 5HT1B Rat 5-Hydroxytryptamine A pIC50 5.52 5.52 5.52 ChEMBL
α1B ADA1B Rat Adrenoceptors A pIC50 8.59 8.59 8.59 ChEMBL
α1A ADA1A Rat Adrenoceptors A pIC50 8.29 8.29 8.29 ChEMBL
α1D ADA1D Human Adrenoceptors A pIC50 8.71 8.71 8.71 ChEMBL
α2B ADA2B Human Adrenoceptors A pIC50 8.76 8.76 8.76 ChEMBL
M5 ACM5 Human Acetylcholine (muscarinic) A pIC50 5.5 5.5 5.5 ChEMBL
α2C ADA2C Human Adrenoceptors A pIC50 7.35 7.35 7.35 ChEMBL
H1 HRH1 Human Histamine A pIC50 8.0 8.0 8.0 ChEMBL
5-HT1A 5HT1A Rat 5-Hydroxytryptamine A pIC50 5.75 5.75 5.75 ChEMBL
α2A ADA2A Human Adrenoceptors A pIC50 7.18 7.18 7.18 ChEMBL
D1 DRD1 Human Dopamine A pIC50 7.5 7.5 7.5 ChEMBL
5-HT6 5HT6R Human 5-Hydroxytryptamine A pIC50 6.95 6.95 6.95 ChEMBL
5-HT2B 5HT2B Human 5-Hydroxytryptamine A pIC50 7.31 7.31 7.31 ChEMBL
5-HT2C 5HT2C Human 5-Hydroxytryptamine A pIC50 7.66 7.66 7.66 ChEMBL
D3 DRD3 Human Dopamine A pIC50 8.33 8.33 8.33 ChEMBL
5-HT2A 5HT2A Human 5-Hydroxytryptamine A pIC50 8.71 8.71 8.71 ChEMBL
D2 DRD2 Human Dopamine A pIC50 8.39 8.39 8.39 ChEMBL
5-HT1A 5HT1A Rat 5-Hydroxytryptamine A pIC50 8.24 8.24 8.24 Drug Central
α1A ADA1A Rat Adrenoceptors A pIC50 8.08 8.08 8.08 Drug Central